SUMMARY The relation between the basal and stimulated gastric acid secretion, plasma gastrin, and the gastric microflora was examined in 45 patients with rheumatoid arthritis. Sixteen patients (36%) had basal achlorhydria, and of these, 10 (22%) had achlorhydria or hypochlorhydria after stimulation with pentagastrin. The peak acid output and acidity showed inverse correlation with the disease duration but were not associated with age or with the degree of physical disability. Hypergastrinaemia was found in nine patients (20%), of whom 6 (13%) had significant titres of parietal cell antibody. The acidity of the peak acid output showed negative correlation with plasma gastrin. It was confirmed that the gastric secretory state is a determinant of plasma gastrin levels and in addition influences the growth of micro-organisms in the gastric lumen. The type of microflora in the non-acid stomach was similar to that found in the saliva. A subgroup of eight females was identified who showed low gastric acid secretion rates, positive bacterial cultures, and atlantoaxial subluxation. Gastrin-and insulin-like immunoreactivities were found in joint fluid. The concentrations reflected their plasma levels, suggesting that the peptides are not released at the inflammatory site, but rather that they reach synovial fluid from circulating blood.
Previous studies have shown that patients below 40 years of age with rheumatoid arthritis (RA) have a reduced gastric secretory capacity. [1] [2] [3] Raised plasma gastrin levels in RA were reported first by Rooney et al in 1973,4 but gastric acid secretion was not examined. An inverse relation between gastric acid secretion and plasma gastrin was reported in such patients by Rowden et al,5 but the frequency of achlorhydria was similar to that of normal controls. In a subsequent study De Witte et al confirmed that increased plasma gastrin was found in patients with achlorhydria or low acid secretion and there was also a higher frequency of reduced gastric acid secretion in the RA patients.6 On the other hand, hypergastrinaemia in the presence of normal parietal cell function has been reported in patients with RA,7 8 and this also has been reported in experimental arthritis in the rat.9 "' Since gastrin may be released from somatic nerves in animals" the Accepted for publication 10 October 1985. Correspondence to Dr K Henriksson, Department of Rheumatology, Karolinska Hospital, -104 01 Stockholm, Sweden. possibility should be considered that hypergastrinaemia in RA may be due partly to extragastric release.
The gastric microbial pattern is known to change in achlorhidna,'2 '3 and it has been suggested by Olhagen,"1Gullberg,'5 and Bennett'6 that bacterial antigens or other biologically active substances from the gastrointestinal microflora may be of importance as a causative or perpetuating factor in RA.
The present study was designed to analyse further the inter-relation between plasma gastrin, basal and stimulated gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis. Determinations of gastrin-and insulin-like immunoreactivity in joint fluid in parallel with blood plasma were also performed in order to assess possible release of these peptides at the inflammatory site. Only five patients were without medication at the time of the study. The remaining 40 patients were receiving non-steroidal anti-inflammatory drugs (NSAIDs). In addition, 14 patients were on maintenance treatment with prednisolone at a daily dose of 5-10 mg and one patient received two to three injections of adrenocorticotrophic hormone every week. In combination with predisolone or NSAIDs, or both, 12 patients had chloroquine and five patients penicillamine. Proresid, an antimitotic cytostatic agent, was given to a further three other patients. Thirteen patients had had only NSAIDs, i.e., first line antirheumatic drugs, during their disease, while the other 32 patients had been further treated with the aforementioned second line or third line drugs, or both, for at least two months.
All patients were evaluated clinically and divided arbitrarily into three groups with low, moderate, and high disease activity respectively. Laboratory parameters for the three groups are reported in Table 1 .
PROCEDURE
The patients fasted overnight with the last medication given 12-16 hours before the study.
In the morning blood for hormone analysis was prepared in prechilled, heparinised tubes and centrifuged at 4°C. The plasma was separated and kept frozen at -70°C until assayed. Saliva samples were obtained from 14 patients and cultured both aerobically and anaerobically.
Before swallowing a tube for the gastric secretion test patients rinsed the mouth with an antiseptic solution of ascorbic acid, sodium bicarbonate, and copper sulphate (Ascoxal). With the patient lying on The saliva specimens from 14 patients and samples of basal and stimulated gastric secretion from 39 patients were transported anaerobically to the laboratory and prepared for microbial cultures within two hours after sampling. Fifty eight gastric samples, 28 each from basal and stimulated periods, were examined both with and without manipulation of the pH. If the pH was below 4 part of the sample was adjusted to pH 7*0 with NaOH, if above 4 to pH 1*8 with HCI. The pH adjustment was made immediately after withdrawal of samples, which were thereafter identically treated.
The samples were suspended in prereduced peptone-yeast extract medium,2I diluted, inoculated in media, and handled as described by Heimdahl and Nord. 22 The aerobic agar plates were incubated for 24 h at 37°C and the anaerobic plates for 48 h at 370C in anaerobic jars (Gas Pak, BBL, Cockeysville, Maryland, USA). They were then examined, and colonies were counted under a stereomicroscope.
Aerobic bacteria were identified biochemically as described elsewhere, 22 Table 2 ). The PAO (Fig. 1) was inversely proportional to disease duration (r= -0*39, n=44, p<001) but showed no correlation with either the inflammatory activity or the degree of physical disability.
The eight female patients with atlantoaxial subluxation had all received second line or third line drugs, or both, and had significantly lower basal (p<0-02) and stimulated (p<0.01) gastric acid secretion rates compared with those of the female patients without this cervical spine complication ( Table 3 ). The four patients with severe atlantoaxial instability had all basal achlorhydria and PAO below 1-3 mmol/30 min. In comparison, male patients with atlantoaxial subluxation had fewer abnormalities of gastric functions.
PLASMA GASTRIN The average fasting plasma gastrin level was 112 pg/ml (range 2 to > 600) and exceeded 100 pg/ml in nine patients. There was no sex difference, and correlations with age or disease duration were absent. There was a statistically significant inverse relationship between log plasma gastrin and PAO (r=-0-51, n=37, p<0-(1) and even more impressively with the acidity of the peak secretion (Fig. 2 ). Female patients who had been treated with second line or third line drugs, or both, had significantly higher plasma gastrin levels than female patients treated only with NSAIDs (p<0-05). Nine patients had significant titres of PCA (1/25 or more). The average PAO in these patients was 2-7 mmol/30 min (range 0-14-8), and the average plasma gastrin was 289 pg/ml (range 14-600). Of nine patients with plasma gastrin levels above 100 pg/ml, six had PCA. The frequency of PCA ( 27 mmol/l had microbial growth (Bacteroides eggerthi).
The number of patients with positive microbial culture in the stimulated period was significantly higher in female patients with atlantoaxial subluxation than in other female patients (Table 3) .
CHARACTERISTICS OF GASTRIC MICROFLORA
The patterns of salivary and gastric microbial growth were similar (Fig. 4) , but only in a single patient (No 12) were the gastric flora identical to the salivary microflora (Fig. 5) 
Discussion
This study first confirms an association between the gastric secretory state and plasma gastrin levels and second demonstrates growth of micro-organisms in the gastric lumen in female patients with severe rheumatoid arthritis.
More than one third of the patients had basal achlorhydria and almost one fourth were achlorhydric or had very low acid response after stimulation. This is in agreement with earlier studies.' 2 3 6 Short et al found that gastric achlorhydria was significantly more frequent in RA patients below 40 years of age, in particular among female patients.2 Thus RA in females is apparently associated with the development of achlorhydria early in life. In addition, the secretory state of the patients showed positive correlation with the duration of the disease, whereas correlation with age was absent.
As observed previously 4 6 8 a large number of RA patients had raised plasma gastrin values. The gastrin levels correlated inversely with the acid secretory status, an observation which is in agreement with the study by De Witte et al. 6 In a few patients in this series a high plasma gastrin coexisted with normal gastric acidity. This combination has been reported previously by Rooney et al both in RA patients7 and in experimental arthritis in the rat." In the experimental series there seemed to be correlation between plasma gastrin and severity of inflammation, but any causative relation remains to be proved. Other peptides, such as substance p,23 may also vary with the degree of inflammation. The gastrin-and insulin-like immunoreactivities in joint Table 4 Concentrations of gastrin and insulin in plasma and joint fluid taken simultaneously in fasting subjects (patients and at variable times after food intake (patients Nos 1012) Biologically active substances derived from gastrointestinal contents or from imbalance in peptide hormone systems, or both, may be of significance in the pathogenesis of RA. As there seem to be an association between destructive RA and low gastric acid secretion it seems important to study further the mechanisms and the consequences of these disturbances in the gastric secretory functions.
